These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 6148005)

  • 1. Coronary heart disease mortality/morbidity and risk in blacks. I: Clinical manifestations and diagnostic criteria: the experience with the Beta Blocker Heart Attack Trial.
    Haywood LJ
    Am Heart J; 1984 Sep; 108(3 Pt 2):787-93. PubMed ID: 6148005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of propanolol in patients entered in the Beta-Blocker Heart Attack Trial with their first myocardial infarction and persistent electrocardiographic ST-segment depression.
    Shivkumar K; Schultz L; Goldstein S; Gheorghiade M
    Am Heart J; 1998 Feb; 135(2 Pt 1):261-7. PubMed ID: 9489974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-blocker heart attack trial: design, methods, and baseline results. Beta-blocker heart attack trial research group.
    Byington RP
    Control Clin Trials; 1984 Dec; 5(4):382-437. PubMed ID: 6151483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Issues in the natural history and treatment of coronary heart disease in black populations: medical management.
    Haywood LJ
    Am Heart J; 1984 Sep; 108(3 Pt 2):683-7. PubMed ID: 6382996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of propranolol on ventricular arrhythmia. The beta-blocker heart attack trial experience.
    Lichstein E; Morganroth J; Harrist R; Hubble E
    Circulation; 1983 Jun; 67(6 Pt 2):I5-10. PubMed ID: 6342839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized trial of propranolol in patients with acute myocardial infarction. II. Morbidity results.
    JAMA; 1983 Nov; 250(20):2814-9. PubMed ID: 6358542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta Blocker Heart Attack Trial: design features.
    Control Clin Trials; 1981 Dec; 2(4):275-85. PubMed ID: 6120793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The beta-blocker heart attack trial. beta-Blocker Heart Attack Study Group.
    JAMA; 1981 Nov; 246(18):2073-4. PubMed ID: 7026815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypertension: possible differential risk for blacks in Beta-Blocker Heart Attack Trial (BHAT).
    Haywood LJ
    Am J Hypertens; 1989 Nov; 2(11 Pt 1):865-8. PubMed ID: 2574045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of propranolol in non-Q-wave acute myocardial infarction in the beta blocker heart attack trial.
    Gheorghiade M; Schultz L; Tilley B; Kao W; Goldstein S
    Am J Cardiol; 1990 Jul; 66(2):129-33. PubMed ID: 2196771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Black-white comparison of indices of coronary heart disease and myocardial infarction in the stepped-care cohort of the Hypertension Detection and Follow-Up Program.
    Langford HG; Oberman A; Borhani NO; Entwisle G; Tung B
    Am Heart J; 1984 Sep; 108(3 Pt 2):797-801. PubMed ID: 6475749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Beta Blocker Heart Attack Trial: recruitment experience.
    Goldstein S; Byington R
    Control Clin Trials; 1987 Dec; 8(4 Suppl):79S-85S. PubMed ID: 2894282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of propranolol on recovery of heart rate variability following acute myocardial infarction and relation to outcome in the Beta-Blocker Heart Attack Trial.
    Lampert R; Ickovics JR; Viscoli CJ; Horwitz RI; Lee FA
    Am J Cardiol; 2003 Jan; 91(2):137-42. PubMed ID: 12521623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results.
    JAMA; 1982 Mar; 247(12):1707-14. PubMed ID: 7038157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Racial differences in incident heart failure during antihypertensive therapy.
    Okin PM; Kjeldsen SE; Dahlöf B; Devereux RB
    Circ Cardiovasc Qual Outcomes; 2011 Mar; 4(2):157-64. PubMed ID: 21304095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Propranolol-induced lipid changes and their prognostic significance after a myocardial infarction: the Beta-Blocker Heart Attack Trial experience.
    Byington RP; Worthy J; Craven T; Furberg CD
    Am J Cardiol; 1990 Jun; 65(20):1287-91. PubMed ID: 2188492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sixteen-year coronary mortality in black and white men with diabetes screened for the Multiple Risk Factor Intervention Trial (MRFIT).
    Vaccaro O; Stamler J; Neaton JD
    Int J Epidemiol; 1998 Aug; 27(4):636-41. PubMed ID: 9758118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Propranolol in acute myocardial infarction: the MILIS experience.
    Rude RE; Buja LM; Willerson JT
    Am J Cardiol; 1986 Apr; 57(12):38F-42F. PubMed ID: 2871744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of carvedilol in patients with impaired left ventricular systolic function following an acute myocardial infarction. How do the treatment effects on total mortality and recurrent myocardial infarction in CAPRICORN compare with previous beta-blocker trials?
    Otterstad JE; Ford I
    Eur J Heart Fail; 2002 Aug; 4(4):501-6. PubMed ID: 12167391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Propranolol therapy in patients with acute myocardial infarction: the Beta-Blocker Heart Attack Trial.
    Goldstein S
    Circulation; 1983 Jun; 67(6 Pt 2):I53-7. PubMed ID: 6342840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.